4Rank MA,Hagan JB,Park MA,et al.The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids:a systematic review and meta-analysis of randomized controlled trials[J].J Allergy Clin Immunol,2013,131(3):724-729.
5Hagan JB,Samant SA,Volcheck GW,et al.The risk of asthma exacerbation after reducing inhaled corticosteroids:a systematic review and meta-analysis of randomized controlled trials[J].Allergy,2014,69(4):510-516.
6Rodrigo GJ,Castro-Rodriguez JA.Daily vs.intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma:a systematic review with meta-analysis[J].Respir Med,2013,107(8):1133-1140.
7Zhang HP,Jia CE,Lv Y,et al.Montelukast for prevention and treatment of asthma exacerbations in adults:Systematic review and metaanalysis[J].Allergy Asthma Proc,2014,35(4):278-287.
8Hon KL,Leung TF,Leung A.Clinical effectiveness and safety of mont-elukast in asthma.What are the conclusions from clinical trials and meta-analyses?[J].Drug Des Devel Ther,2014,26(8):839-850.
9Nie H,Zhang G,Liu M,et al.Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma[J].Respir Med,2013,107(3):347-354.
10Margay SM,Farhat S,Kaur S,et al.To study the efficacy and safety of doxophylline and theophylline in bronchial asthma[J].J Clin Diagn Res,2015,9(4):FC05-FC08.
